合計 50 件の最近のインサイダー取引記録が記録されています Citius Pharmaceuticals, Inc. (CTXR), 内訳は 37 件の買い および 10 件の売り. インサイダー買い総額は $5.54M インサイダー売り総額は $11.12M.
最近活動のある主要インサイダーには Holubiak Myron Z, Mazur Leonard L, Mcgrath Dennis M. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CTXR
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-08-08 |
Holubiak Myron Z |
Vice Chairman |
株式返還 |
31,373 |
$28.75 |
$901.97K |
- |
| 2025-08-08 |
Mazur Leonard L |
Chief Executive Officer |
株式返還 |
89,388 |
$19.25 |
$1.72M |
- |
| 2024-11-07 |
Holubiak Myron Z |
Vice Chairman |
RSU 付与（制限付株式） |
75,000 |
$0.38 |
$28.5K |
75,000 |
| 2024-11-07 |
Mcgrath Dennis M |
Director |
RSU 付与（制限付株式） |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
RSU 付与（制限付株式） |
600,000 |
$0.38 |
$228K |
600,000 |
| 2024-11-07 |
Dutia Suren G |
Director |
RSU 付与（制限付株式） |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Webb Carol |
Director |
RSU 付与（制限付株式） |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Holuka Eugene Myron |
Director |
RSU 付与（制限付株式） |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Bartushak Jaime |
Chief Financial Officer |
RSU 付与（制限付株式） |
350,000 |
$0.38 |
$133K |
350,000 |
| 2024-11-07 |
Czuczman Myron |
Chief Medical Officer |
RSU 付与（制限付株式） |
300,000 |
$0.38 |
$114K |
300,000 |
| 2024-11-07 |
Smith Robert Joseph |
Director |
RSU 付与（制限付株式） |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-09-25 |
Holubiak Myron Z |
Vice Chairman |
株式返還 |
558,597 |
$0.77 |
$430.12K |
- |
| 2024-09-25 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
株式返還 |
2,234,700 |
$0.77 |
$1.72M |
- |
| 2024-08-14 |
Holubiak Myron Z |
Vice Chairman |
株式返還 |
784,314 |
$1.15 |
$901.96K |
- |
| 2024-08-14 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
株式返還 |
3,137,255 |
$1.15 |
$3.61M |
- |
| 2024-04-03 |
Holubiak Myron Z |
Vice Chairman |
株式返還 |
129,450 |
$1.42 |
$183.82K |
- |
| 2024-04-03 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
株式返還 |
1,165,048 |
$1.42 |
$1.65M |
- |
| 2024-03-14 |
Smith Robert Joseph |
Director |
RSU 付与（制限付株式） |
75,000 |
$0.69 |
$51.75K |
75,000 |
| 2024-03-13 |
Holuka Eugene Myron |
Director |
オプション行使（売却） |
2,415 |
$0.02 |
$36.23 |
- |
| 2024-03-12 |
Smith Robert Joseph |
Director |
不明 |
- |
- |
- |
- |
| 2024-03-04 |
Webb Carol |
Director |
オプション行使（売却） |
12,071 |
$0.02 |
$181.07 |
- |
| 2023-10-10 |
Holubiak Myron Z |
Vice Chairman |
RSU 付与（制限付株式） |
400,000 |
$0.70 |
$280K |
400,000 |
| 2023-10-10 |
Mcgrath Dennis M |
Director |
RSU 付与（制限付株式） |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
RSU 付与（制限付株式） |
550,000 |
$0.70 |
$385K |
550,000 |
| 2023-10-10 |
Dutia Suren G |
Director |
RSU 付与（制限付株式） |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Webb Carol |
Director |
RSU 付与（制限付株式） |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Holuka Eugene Myron |
Director |
RSU 付与（制限付株式） |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Bartushak Jaime |
Chief Financial Officer |
RSU 付与（制限付株式） |
300,000 |
$0.70 |
$210K |
300,000 |
| 2023-10-10 |
Czuczman Myron |
Chief Medical Officer |
RSU 付与（制限付株式） |
300,000 |
$0.70 |
$210K |
300,000 |
| 2023-02-07 |
Mcgrath Dennis M |
Director |
不明 |
- |
- |
- |
- |
| 2023-02-07 |
Mcgrath Dennis M |
Director |
RSU 付与（制限付株式） |
75,000 |
$1.42 |
$106.5K |
75,000 |
| 2022-10-04 |
Holubiak Myron Z |
Vice Chairman |
RSU 付与（制限付株式） |
400,000 |
- |
- |
400,000 |
| 2022-10-04 |
Safir Howard |
Director |
RSU 付与（制限付株式） |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Mazur Leonard L |
Executive Chairman |
RSU 付与（制限付株式） |
550,000 |
- |
- |
550,000 |
| 2022-10-04 |
Dutia Suren G |
Director |
RSU 付与（制限付株式） |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Webb Carol |
Director |
RSU 付与（制限付株式） |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Kane William |
Director |
RSU 付与（制限付株式） |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Holuka Eugene Myron |
Director |
RSU 付与（制限付株式） |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Bartushak Jaime |
Chief Financial Officer |
RSU 付与（制限付株式） |
300,000 |
- |
- |
300,000 |
| 2022-10-04 |
Czuczman Myron |
Chief Medical Officer |
RSU 付与（制限付株式） |
300,000 |
- |
- |
300,000 |
| 2022-10-04 |
Mazur Leonard L |
10 Percent Owner, Officer: Executive Chairman |
不明 |
- |
- |
- |
- |
| 2021-10-11 |
Holubiak Myron Z |
President and CEO |
RSU 付与（制限付株式） |
15,000 |
$2.04 |
$30.6K |
15,000 |
| 2021-10-11 |
Safir Howard |
Director |
RSU 付与（制限付株式） |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Mazur Leonard L |
10 Percent Owner, Officer: Executive Chairman |
RSU 付与（制限付株式） |
650,000 |
$2.04 |
$1.33M |
650,000 |
| 2021-10-11 |
Dutia Suren G |
Director |
RSU 付与（制限付株式） |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Webb Carol |
Director |
RSU 付与（制限付株式） |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Kane William |
Director |
RSU 付与（制限付株式） |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Holuka Eugene Myron |
Director |
RSU 付与（制限付株式） |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Bartushak Jaime |
Chief Financial Officer |
RSU 付与（制限付株式） |
300,000 |
$2.04 |
$612K |
300,000 |
| 2021-10-11 |
Czuczman Myron |
Chief Medical Officer |
RSU 付与（制限付株式） |
300,000 |
$2.04 |
$612K |
300,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
